You are viewing: UK Cell Analysis Market analysis
Part of: Cell Analysis Market (Global)

The UK Cell Analysis Market was valued at $545.69 Million in 2023 and projected to reach to $934.24 Million by 2028, representing a compound annual growth rate of 11.4%. The UK cell analysis market is positioned for sustained expansion through 2028, driven by increasing healthcare expenditure and the NHS's commitment to adopting innovative diagnostic technologies.

UK Cell Analysis Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Cell Analysis Market Trends and Insights

  • The UK market is expected to reach $934.24 million by 2028, reflecting a compound annual growth rate of 11.4%, driven by increasing adoption of advanced diagnostic technologies and rising investment in life sciences research.
  • The UK's robust healthcare infrastructure and emphasis on precision medicine are key catalysts propelling the cell analysis sector forward during this forecast period..

Key Market Statistics

  • CAGR (2023-2028) 11.4% CAGR
  • Market Size, 2023 ~USD 545.69 Million
  • Forecast, 2028 ~USD 934.24 Million
  • Country UK

UK Cell Analysis Market Overview

Market Valuation Growth :

The UK cell analysis market reached $545.69 million in 2023 and is projected to grow to $934.24 million by 2028, representing a robust 11.4% CAGR, outpacing the global average of 10.9%.

Advanced Diagnostic Adoption :

UK healthcare institutions are increasingly adopting cutting-edge cell analysis technologies, driven by NHS modernization initiatives and growing demand for precision medicine in clinical diagnostics.

Life Sciences Investment Surge :

Significant government and private sector investment in UK life sciences research, particularly in genomics and cellular therapeutics, is accelerating demand for sophisticated cell analysis solutions.

Healthcare Infrastructure Strength :

The UK's well-established healthcare system, combined with leading academic research institutions and biotech clusters, creates a favorable environment for cell analysis technology deployment and innovation.

UK Cell Analysis Market Dynamics

  • Rising prevalence of chronic diseases and cancer diagnoses necessitates advanced cell analysis capabilities for early detection and personalized treatment planning.
  • UK pharmaceutical and biotechnology companies are investing heavily in cell-based research, further propelling market demand.
  • Regulatory support from the MHRA and collaboration between academic institutions and industry stakeholders will continue to foster market growth.
  • The shift towards automation and AI-integrated cell analysis platforms presents significant opportunities for market players targeting the UK healthcare sector..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • The UK cell analysis market is valued at $545.69 million in 2023 and is projected to grow to $934.24 million by 2028.
      • The UK market exhibits a CAGR of 11.4%, outpacing global growth rates and indicating strong regional demand.
      • The UK's advanced healthcare system and research capabilities are driving adoption of cell analysis technologies.
      • Investment in precision medicine and diagnostic innovation continues to fuel market expansion across the UK.

      Cell Analysis Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment SINGLE-CELL ANALYSIS (Process)
      Forecast Period 2023–2028
      Growth Rate CAGR of 10.9% from 2023 to 2028
      Largest Segment REAGENTS & CONSUMABLES (Product & Service)
      Market Size Base Year (Billions) ~USD 20.21 (2023)
      Revenue Forecast (Billions) ~USD 33.9 (2028)
      Segments Covered Product & Service, Technique, Process, End User

      UK Cell Analysis Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Product & Service

      • Accessories
      • Instruments
      • Reagents & Consumables
      • Services
      • Software

      By Technique

      • Cell Microarrays
      • Flow Cytometry
      • High-Content Screening
      • Microscopy
      • Other Techniques
      • Pcr
      • Spectrophotometry

      By Process

      • Cell Counting And Quality Control
      • Cell Identification
      • Cell Interaction
      • Cell Proliferation
      • Cell Signaling Pathways/ Signal Transduction
      • Cell Signaling Pathways/Signal Transduction
      • Cell Structure Study
      • Cell Viability
      • Single-Cell Analysis
      • Target Identification And Validation

      By End User

      • Academic And Research Institutes
      • Hospitals And Clinical Testing Laboratories
      • Other End Users
      • Pharmaceutica And Biotechnology Companies
      • Pharmaceutical & Biotechnology Companies
      • Pharmaceutical And Biotechnology Companies

      UK: CELL ANALYSIS MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      ACADEMIC AND RESEARCH INSTITUTES181.24209.8230.11253.77281.89315.39355.39403.6711.9
      HOSPITALS AND CLINICAL TESTING LABORATORIES231.41269.29296.92329.16367.55413.38468.24534.6112.5
      OTHER END USERS257.8299.66330.02365.44407.6457.89518.08590.8612.4
      PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES357.06412.73452.02497.76552.1616.78693.96787.0511.7
      TOTAL1027.511191.471309.071446.131609.141803.442035.672316.1912.1

      Target Audience

      • UK Healthcare Providers : NHS trusts, private hospitals, and diagnostic centers need market intelligence to evaluate cell analysis technology investments and understand competitive offerings in the UK market.
      • Medical Device Manufacturers : Global and UK-based cell analysis equipment manufacturers require detailed market sizing and growth projections to optimize product development and sales strategies for the British market.
      • Life Sciences Investors : Venture capital firms, private equity investors, and institutional investors need UK-specific market data to assess investment opportunities in cell analysis technology companies and biotech startups.
      • Pharmaceutical & Biotech Companies : UK-based and international pharma firms conducting clinical research need market insights to understand cell analysis adoption rates and technology trends affecting their R&D operations.
      • Healthcare Consultants & Analysts : Management consulting firms and market research professionals require granular UK market data to support client advisory services and competitive benchmarking in the healthcare diagnostics sector.

      Key Companies in the UK Cell Analysis Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing & packaging),Pharmaceutical development services (formulation & clinical supply),Drug substance services (API & biologics),
      ABCAM PLCUnited KingdomPrivate CompanyPrimary and secondary antibodies,Conjugated antibodies and conjugation kits,Singleplex immunoassays,
      BRUKER CORPORATIONUnited StatesPublic CompanyBSI BioSpin (NMR/EPR and preclinical imaging),BSI CALID (mass spectrometry and diagnostics),BSI Nano (X-ray, AFM, microscopy, nano-metrology),
      WAFERGEN BIO-SYSTEMSUnited StatesPrivate CompanySmartChip Real-Time PCR and Target Enrichment Systems,SmartChip Single-Cell Isolation System,Apollo 324 Library Preparation System and Reagents,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      DANAHERUnited StatesPublic CompanyBiotechnology (bioprocessing and single-use solutions),Life Sciences (instruments, genomics, and analytical systems),Diagnostics (clinical instruments and consumables),
      GENERAL ELECTRICUnited StatesPublic CompanyCommercial Engines & Services,Defense & Propulsion Technologies,Additive, Components & Other Systems,
      MERCK KGAAGermanyPublic CompanyLife Science (reagents, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, equipment),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research and Bioprocess,
      STANDARD BIOTOOLSUnited StatesPublic CompanyProteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and legacy systems),Services, software, and other,
      OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Urology (visualization, stone management, BPH, bladder cancer),Respiratory (bronchoscopy, lung cancer, COPD),

      PATHEON INC

      Patheon Inc. is a Netherlands-based private company with 9,100 employees operating in the pharmaceutical and biotechnology services sector.

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees providing research reagents and tools for the life sciences industry.

      BRUKER CORPORATION

      Bruker Corporation is a publicly traded U.S. company founded in 1960 with 11,085 employees manufacturing scientific instruments and analytical solutions.

      WAFERGEN BIO-SYSTEMS

      WaferGen Bio-Systems is a U.S. private company founded in 2002 with 56 employees developing microfluidic and genomic analysis technologies.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a publicly traded U.S. company founded in 1956 with 125,000 employees serving the life sciences, analytical, and diagnostics markets.

      DANAHER

      Danaher is a publicly traded U.S. company founded in 1969 with 59,000 employees operating across diversified industrial and life sciences sectors.

      GENERAL ELECTRIC

      General Electric is a publicly traded U.S. company founded in 1892 with 57,000 employees operating across industrial, power, and healthcare sectors.

      MERCK KGAA

      Merck KGaA is a publicly traded German company founded in 1668 with 59,077 employees engaged in pharmaceuticals, life sciences, and performance materials.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a publicly traded U.S. company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a publicly traded U.S. company founded in 1952 with 7,450 employees manufacturing clinical diagnostics and life science research products.

      STANDARD BIOTOOLS

      Standard Biotools is a publicly traded U.S. company founded in 1999 with 387 employees developing microfluidic and genomic analysis platforms.

      OLYMPUS CORPORATION

      Olympus Corporation is a publicly traded Japanese company founded in 1919 with 28,138 employees manufacturing optical and digital precision instruments.

      Reasons to Buy this Report

      • UK-Specific Market Sizing : Access precise valuation data for the UK cell analysis market with verified 2023 baseline ($545.69M) and 2028 forecasts ($934.24M), enabling accurate budget allocation and investment planning.
      • Competitive Landscape Intelligence : Understand UK market dynamics, key players, and competitive positioning specific to the British healthcare system, NHS procurement processes, and regulatory environment.
      • Growth Driver Analysis : Identify UK-specific growth catalysts including NHS digital transformation, life sciences sector expansion, and government R&D initiatives driving the 11.4% CAGR.
      • Strategic Market Entry Planning : Develop targeted go-to-market strategies for the UK with insights into regional healthcare infrastructure, reimbursement pathways, and institutional buying preferences.
      • Investment Decision Support : Make informed investment and partnership decisions with comprehensive UK market data, trend analysis, and forecast reliability to support business expansion in the British healthcare sector.

      Frequently asked questions

      What is the current size of the UK cell analysis market?

      The UK cell analysis market was valued at $545.69 million in 2023 and is expected to reach $934.24 million by 2028.

      What is the growth rate of the UK cell analysis market?

      The UK cell analysis market is growing at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2028.

      What factors are driving growth in the UK cell analysis market?

      Key drivers include increased adoption of advanced diagnostic technologies, rising investment in life sciences research, and the UK's emphasis on precision medicine and personalized healthcare solutions.

      How does the UK market compare to global cell analysis market trends?

      The UK market's CAGR of 11.4% exceeds the global CAGR of 10.9%, indicating stronger regional growth momentum and higher market penetration of cell analysis technologies.

      What is the forecast market size for the UK cell analysis market in 2028?

      The UK cell analysis market is projected to reach $934.24 million by 2028, representing significant expansion from the 2023 baseline of $545.69 million.

      RESEARCH METHODOLOGY

      This study involved four major activities in estimating the current size of the cell analysis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), International Agency for Research on Cancer (IARC), Centers for Disease Control and Prevention (CDC), Society for Laboratory Automation and Screening (SLAS), Centers for Medicare & Medicaid Services (CMS), National Cancer Institute (NCI), European Commission (EC), American Society for Cell Biology (ASCB), European Society for Toxicology In Vitro (ESTIV), European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan Society for Cell Biology (JSCB), Shanghai Institute of Biochemistry and Cell Biology (SIBCB), Indian Society of Cell Biology (ISCB), Food and Drug Administration (FDA), Society of Biomolecular Imaging and Informatics (SBI2), Annual Reports, SEC Filings, Investor Presentations, Press Releases, Conferences, Journals, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

      Cell Analysis Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2021, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the cell analysis business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Cell Analysis Market Size, and Share

      Data Triangulation

      After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Cell analysis is a technique used to study groups of cells and individual cells based on multiple parameters. It is used to measure cell properties such as size, shape, presence of specific proteins, proliferation, growth, morphology, porosity, and complexity.

      Cell analysis products are used in various processes, which include cell identification, cell viability, cell proliferation, cell structure study, cell signaling pathway/signal transduction, cell counting & quality control, target identification & validation, cell interaction, and single-cell analysis. These processes are carried out by various end users such as hospitals & clinical testing laboratories, academic and research institutes, pharmaceutical & biotechnology companies, and other end users (CROs, cell culture collection repositories, food & beverage manufacturers, environmental monitoring organizations, forensic laboratories, and blood banks).

      Key Stakeholders

      • Pharmaceutical and biopharmaceutical companies
      • Manufacturers of cell analysis equipment
      • Contract research organizations (CROs)
      • Life science research institutes
      • Venture capitalists
      • Research & consulting firms

      Report Objectives

      • To define, describe, and forecast the global cell analysis market based on the product & service, technique, process, end user and region
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, and opportunities)
      • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall cell analysis market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
      • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the cell analysis market.

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Company Information

      • An additional five company profiles

      Get the Full Cell Analysis Market Report

      Full forecast, segment splits, and company analysis for all Cell Analysis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status